Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Diabetes & Metabolism Journal
>
2015
>
39
>
4
Volume:
39
Issue:
4
1. Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52).
Page:350—351
2. Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52).
Page:348—349
3. Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.
Page:342—347
4. Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus.
Page:335—341
5. Maximal Fat Oxidation Rate during Exercise in Korean Women with Type 2 Diabetes Mellitus.
Page:328—334
6. Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population.
Page:321—327
7. Maternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 Diabetes.
Page:316—320
8. Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea.
Page:307—315
9. Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus.
Page:304—306
10. Probiotics as Complementary Treatment for Metabolic Disorders.
Page:291—303
11. Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus.
Page:283—290
12. Glycemic Variability: How Do We Measure It and Why Is It Important?.
Page:273—282
